Arundhati Parmar

A private equity firm announced the merger of three assets that can reduce payers's headaches when it comes to making sure that provider-submitted claims are accurate. In turn providers can get paid quickly.

Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera's chief medical officer and the company has built a digital pathology tool for prostate cancer patients.

FarmboxRx CEO Ashley Tyrner explains why she never accepted outside capital after launching her company that serves nutritional needs of Medicaid and Medicare members.

A panel of experts said the HLTH conference agrred that states with strict abortion measures are likely to see negative economic impact as medical residents decline to go to them for training and physicians move out.

How are employers tackling the current landscape of healthcare costs? We turned to Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, a group of regional coalitions representing self-insured employers large and small that cover roughly 40 million people.

I met a mix of biotech and healthtech companies at HLTH affecting everything from drug development, drug efficacy to controlling specialty care costs and managing chronic diseases.

In an interview, Rabah talked about the promise of AI, where it can have the most impact, while also responding to the IRA and high drug prices in the United States.

The Glp-1 battle heats with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more weight on average in 72 weeks than those on Novo Nordisk's Wegovy.

Dr. Maria Pulido, chief medical officer, of Ascension St. Vincents, explains why he believes tools like Wellsheet makes the hospital care team's job so much easier.

Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world's first, lifetime guarantee on shoulder replacement surgeries.